Patent · US Active

Insulin analogs with reduced affinity to insulin receptor and use thereof

US11396534B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignees

HANMI PHARM. CO., LTD. · KR
Sanofi-Aventis Deutschland GMBH · DE

Inventors

In Young Choi · Hwaseong-si, KR
Sung Youb Jung · Suwon-si, KR
Marcus Hermann KORN · Offenbach, DE
Stefan Guessregen · Frankfurt am Main, DE
Norbert Tennagels · Siegburg, DE

Key dates

Filing date	Sep 22, 2017
Grant date	Jul 26, 2022
Priority date	—
Expiry date	Sep 22, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a novel insulin analog, use thereof, and a method for preparing the analog.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.